InnAccel

InnAccel is a MedTech company founded in 2012 with the vision of achieving global leadership in MedTech innovation for India and global markets. The company's mission is to create a portfolio of medical products that are designed, engineered, and priced for global markets. Using the Stanford Biodesign process, InnAccel identifies critical unmet healthcare needs and focuses on developing regulatory-certified, world-class products to address these needs. The company's portfolio currently comprises three novel products that target a global market worth over $10 billion and address conditions that contribute to almost a million deaths in India annually. Based in India, InnAccel has over 30 professionals, including engineers, designers, and clinicians, working at its Innovation Center. The team is led by individuals with a combination of entrepreneurial, technology development, and clinical experience. Moreover, the company has a strategic advisory board consisting of industry leaders and a network of 50+ advisors/mentors to guide project teams. Mount Judi Ventures, Siraj Dhanani, and Vijayarajan Avr collectively made a $1.50M seed round investment in InnAccel on 20 October 2020. With a focus on transforming healthcare and aiming for global leadership in medical technology for emerging markets by 2025, InnAccel stands as a promising player in the MedTech industry.